Globe Life Inc. (NYSE:GL ) Q2 2025 Earnings Conference Call July 24, 2025 11:00 AM ET Company Participants Frank Martin Svoboda - Co-Chairman & Co-CEO James Matthew Darden - Co-Chairman & Co-CEO Stephen Mota - Senior Director of Investor Relations Thomas Peter Kalmbach - Executive VP & CFO Conference Call Participants Andrew Scott Kligerman - TD Cowen, Research Division Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Jack Matten - BMO Capital Markets Equity Research Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division John Bakewell Barnidge - Piper Sandler & Co., Research Division Mark Douglas Hughes - Truist Securities, Inc., Research Division Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L. Kamath - Jefferies LLC, Research Division Thomas George Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Collin Carmichael - Autonomous Research US LP Wilma Carter Jackson Burdis - Raymond James & Associates, Inc., Research Division Operator Hello, and welcome to Globe Life Inc. Second Quarter Earnings Release Call.
GL's Q2 earnings increase 10% as strong Life and Health premiums offset declines in investment income and rising expenses.
Globe Life (GL) came out with quarterly earnings of $3.27 per share, beating the Zacks Consensus Estimate of $3.25 per share. This compares to earnings of $2.97 per share a year ago.
![]() TMJ 3 weeks ago | Other | €0.23 Per Share |
![]() TMJ 3 months ago | Other | €0.23 Per Share |
![]() TMJ 6 months ago | Other | €0.21 Per Share |
![]() TMJ 9 months ago | Other | €0.21 Per Share |
![]() TMJ 5 Jul 2024 | Other | €0.21 Per Share |
22 Oct 2025 (In 2 months) Date | | 3.97 Cons. EPS | - EPS |
21 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
23 Jul 2025 Date | | 3.25 Cons. EPS | - EPS |
22 Jul 2025 Date | | - Cons. EPS | - EPS |
7 Jul 2025 Date | | 3.25 Cons. EPS | - EPS |
![]() TMJ 3 weeks ago | Other | €0.23 Per Share |
![]() TMJ 3 months ago | Other | €0.23 Per Share |
![]() TMJ 6 months ago | Other | €0.21 Per Share |
![]() TMJ 9 months ago | Other | €0.21 Per Share |
![]() TMJ 5 Jul 2024 | Other | €0.21 Per Share |
22 Oct 2025 (In 2 months) Date | | 3.97 Cons. EPS | - EPS |
21 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
23 Jul 2025 Date | | 3.25 Cons. EPS | - EPS |
22 Jul 2025 Date | | - Cons. EPS | - EPS |
7 Jul 2025 Date | | 3.25 Cons. EPS | - EPS |
Insurance - Life Industry | Financial Services Sector | Frank Martin Svoboda CEO | XBER Exchange | US37959E1029 ISIN |
US Country | 3,732 Employees | - Last Dividend | 2 Jul 2014 Last Split | 30 Dec 1987 IPO Date |
Globe Life Inc. engages in providing a diverse range of life and supplemental health insurance products along with annuities aimed predominantly at lower middle- and middle-income families across the United States. This ambit is structured into four operational segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Initially known as Torchmark Corporation, it underwent a name change to Globe Life Inc. in August 2019, signaling a new era under a brand that reflects its comprehensive offerings in the life insurance market. Founded in 1900, the company has its headquarters located in McKinney, Texas, marking over a century of service in the insurance sector. Globe Life Inc. leverages a variety of channels to market and sell its products, including direct to consumer campaigns, exclusive agencies, and a network of independent agents, ensuring a widespread reach to its target demographic.